Advisory Committee on Breast Cancer in Young Women (ACBCYW), 15621 [2015-06644]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Centers for Disease Control and
Prevention
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC review
(2015/05).
Date: May 27, 2015.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Suite 959,
Bethesda, MD 20892, (301) 451–3397,
sukharem@mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; 2015–10 SBIR HD
Review.
Date: June 24, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Ruth Grossman, DDS,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institute of Health, 6707 Democracy
Boulevard, Rm. 960, Bethesda, MD 20892,
(301) 496–8775, grossmanrs@mail.nih.gov.
Dated: March 19, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06698 Filed 3–23–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
01:09 Mar 24, 2015
Jkt 235001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 1:00 p.m.–4:00 p.m.
EST, April 17, 2015.
Place: This meeting is accessible by
teleconference and web access.
Teleconference and web access login
information is as follows:
Toll-Free Telephone: 1–800–369–
1856, Participant passcode: 1927394.
Net Conference and Web URL:
For Participants:
URL: https://www.mymeetings.com/
nc/join/.
Conference number: PW1978421,
Audience passcode: 1927394 and:
https://www.mymeetings.com/nc/
join.php?i=PW1978421&p=1927394
&t=c.
Status: Open to the public, limited
only by the net conference and audio
phone lines available.
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters For Discussion: The agenda
will include discussions on the current
and emerging topics related to breast
cancer in young women. These may
include risk communication and health
education, as well as approaches to
increase awareness of clinicians/
practitioners regarding topics such as
breast cancer risk, breast health,
symptoms, diagnosis, and treatment of
breast cancer in young women.
Discussions for formal
recommendations will take place.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: All
ACBCYW Meeting participants must
register for the meeting online at least 3
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
15621
business days in advance at https://
www.cdc.gov/cancer/breast/what_cdc_is
_doing/meetings.htm. Please complete
all the required fields before submitting
your registration and submit no later
than April 14, 2015.
Contact Person For More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE., Mailstop K52, Atlanta, Georgia,
30341, Telephone (770) 488–4518, Fax
(770) 488–4760 Email: acbcyw@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–06644 Filed 3–23–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Times and Dates:
12:30 p.m.–5:00 p.m., April 15, 2014
8:30 a.m.–12:00 p.m., April 16, 2014
Place: CDC, 1600 Clifton Road NE.,
Tom Harkin Global Communications
Center, Building 19, Auditorium B,
Atlanta, Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people. This meeting will also be
Webcast, please see information below.
Purpose: This Committee is charged
with providing scientific and technical
advice and guidance to the Secretary of
Health and Human Services (HHS); the
Assistant Secretary for Health; the
Director, Centers for Disease Control
and Prevention; the Commissioner,
Food and Drug Administration (FDA);
and the Administrator, Centers for
Medicare and Medicaid Services (CMS).
The advice and guidance pertain to
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06644]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women (ACBCYW)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 1:00 p.m.-4:00 p.m. EST, April 17, 2015.
Place: This meeting is accessible by teleconference and web access.
Teleconference and web access login information is as follows:
Toll-Free Telephone: 1-800-369-1856, Participant passcode: 1927394.
Net Conference and Web URL:
For Participants:
URL: https://www.mymeetings.com/nc/join/.
Conference number: PW1978421, Audience passcode: 1927394 and:
https://www.mymeetings.com/nc/join.php?i=PW1978421&p=1927394&t=c.
Status: Open to the public, limited only by the net conference and
audio phone lines available.
Purpose: The committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters For Discussion: The agenda will include discussions on the
current and emerging topics related to breast cancer in young women.
These may include risk communication and health education, as well as
approaches to increase awareness of clinicians/practitioners regarding
topics such as breast cancer risk, breast health, symptoms, diagnosis,
and treatment of breast cancer in young women. Discussions for formal
recommendations will take place.
Agenda items are subject to change as priorities dictate.
Online Registration Required: All ACBCYW Meeting participants must
register for the meeting online at least 3 business days in advance at
https://www.cdc.gov/cancer/breast/what_cdc_is_doing/meetings.htm. Please
complete all the required fields before submitting your registration
and submit no later than April 14, 2015.
Contact Person For More Information: Temeika L. Fairley, Ph.D.,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop
K52, Atlanta, Georgia, 30341, Telephone (770) 488-4518, Fax (770) 488-
4760 Email: acbcyw@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-06644 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P
